News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,206 Results
Type
Article (87772)
Company Profile (824)
Press Release (778594)
Multimedia
Podcasts (187)
Webinars (28)
Section
Business (233174)
Career Advice (4144)
Deals (39838)
Drug Delivery (144)
Drug Development (91362)
Employer Resources (203)
FDA (18359)
Job Trends (17415)
News (397722)
Policy (39949)
Tag
Academia (3006)
Academic (2)
Accelerated approval (26)
Adcomms (35)
Allergies (135)
Alliances (56981)
ALS (170)
Alzheimer's disease (1762)
Antibody-drug conjugate (ADC) (307)
Approvals (18478)
Artificial intelligence (582)
Autoimmune disease (136)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (625)
Cancer (4722)
Cardiovascular disease (410)
Career advice (3566)
Career pathing (40)
CAR-T (291)
CDC (59)
Celiac Disease (1)
Cell therapy (789)
Cervical cancer (37)
Clinical research (76592)
Collaboration (1616)
Company closure (5)
Compensation (1075)
Complete response letters (65)
COVID-19 (2980)
CRISPR (93)
C-suite (748)
Cystic fibrosis (148)
Data (5880)
Decentralized trials (2)
Denatured (68)
Depression (133)
Diabetes (498)
Diagnostics (7176)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (276)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99897)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134551)
Executive appointments (1010)
FDA (21241)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1443)
Gene editing (202)
Generative AI (60)
Gene therapy (628)
GLP-1 (1084)
Government (5421)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (277)
Immuno-oncology (42)
Indications (77)
Infectious disease (3251)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (112)
Intellectual property (218)
Interviews (816)
IPO (17943)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (39)
Legal (10154)
Liver cancer (95)
Longevity (14)
Lung cancer (650)
Lymphoma (361)
Machine learning (40)
Management (66)
Manufacturing (753)
MASH (166)
Medical device (14972)
Medtech (15012)
Mergers & acquisitions (22881)
Metabolic disorders (1300)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (323)
Neuropsychiatric disorders (86)
Neuroscience (2964)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (624)
Opinion (327)
Ovarian cancer (153)
Pain (192)
Pancreatic cancer (204)
Parkinson's disease (273)
Partnered (34)
Patents (470)
Patient recruitment (412)
Peanut (59)
People (66648)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23654)
Phase II (33240)
Phase III (25058)
Pipeline (3953)
Policy (319)
Postmarket research (3554)
Preclinical (10669)
Press Release (72)
Prostate cancer (230)
Psychedelics (53)
Radiopharmaceuticals (290)
Rare diseases (811)
Real estate (7436)
Recruiting (80)
Regulatory (28593)
Reports (65)
Research institute (2716)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (240)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (117)
Vaccines (1108)
Venture capital (80)
Weight loss (434)
Women's health (79)
Worklife (21)
Date
Today (197)
Last 7 days (641)
Last 30 days (2714)
Last 365 days (33348)
2025 (32742)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (51337)
Australia (9019)
California (10863)
Canada (3176)
China (1067)
Colorado (457)
Connecticut (481)
Delaware (328)
Europe (117996)
Florida (1591)
Georgia (351)
Hawaii (3)
Idaho (68)
Illinois (896)
India (62)
Indiana (524)
Iowa (22)
Japan (382)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1397)
Massachusetts (8038)
Michigan (343)
Minnesota (630)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2957)
New Mexico (32)
New York (2901)
North Carolina (1539)
North Dakota (10)
Northern California (5125)
Ohio (331)
Oklahoma (22)
Oregon (52)
Pennsylvania (2200)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4174)
Tennessee (168)
Texas (1708)
United States (39493)
Utah (325)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (919)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,206 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
December 18, 2025
·
6 min read
Press Releases
InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
December 18, 2025
·
2 min read
Press Releases
U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)
December 18, 2025
·
33 min read
Press Releases
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
December 18, 2025
·
15 min read
Press Releases
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
December 18, 2025
·
2 min read
Press Releases
Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development
December 18, 2025
·
4 min read
Press Releases
Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes
December 18, 2025
·
3 min read
Press Releases
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
·
1 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
·
14 min read
Press Releases
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 18, 2025
·
3 min read
1 of 86,721
Next
